The cyclin-dependent kinase inhibitor p27Kip1 interacts with the aryl hydrocarbon receptor and negatively regulates its transcriptional activity

FEBS Lett. 2022 Aug;596(16):2056-2071. doi: 10.1002/1873-3468.14434. Epub 2022 Jul 22.

Abstract

p27Kip1 functions to coordinate cell cycle progression through the inhibition of cyclin-dependent kinase (CDK) complexes. p27Kip1 also exerts distinct activities beyond CDK-inhibition, including functioning as a transcriptional regulator. The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor with diverse biological roles. The regulatory inputs that control AhR-mediated transcriptional responses are an active area of investigation. AhR was previously established as a direct regulator of p27Kip1 transcription. Here, we report the physical interaction of AhR and p27Kip1 and show that p27Kip1 expression negatively regulates AhR-mediated transcription. p27Kip1 knockout cells display increased AhR nuclear localisation and significantly higher expression of AhR target genes. This work thus identifies new regulatory cross-talk between p27Kip1 and AhR.

Keywords: aryl hydrocarbon receptor; cyclin-dependent kinase inhibitor; transcriptional regulation; xenobiotics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell Cycle Proteins
  • Cyclin-Dependent Kinase Inhibitor p27
  • Cyclin-Dependent Kinases*
  • Gene Expression Regulation
  • Receptors, Aryl Hydrocarbon*

Substances

  • Cell Cycle Proteins
  • Receptors, Aryl Hydrocarbon
  • Cyclin-Dependent Kinase Inhibitor p27
  • Cyclin-Dependent Kinases